Literature DB >> 8809830

Activity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy.

D V Pow1, W Baldridge, D K Crook.   

Abstract

We have raised antisera against the GABA analogues gamma-vinyl GABA, diaminobutyric acid and gabaculine. These analogues are thought to be substrates for high-affinity GABA transporters. Retinae were exposed to micromolar concentrations of these analogues in the presence or absence of uptake inhibitors and then fixed and processed for immunocytochemistry at the light and electron microscopic levels. Immunolabelling for gamma-vinyl GABA revealed specific labelling of GABAergic amacrine cells and displaced amacrine cells in retinae of rabbits, cats, chickens, fish and a monkey. GABA-containing horizontal cells of cat and monkey retinae failed to exhibit labelling for gamma-vinyl GABA, suggesting that they lacked an uptake system for this molecule. In light-adapted fish, gamma-vinyl GABA was readily detected in H1 horizontal cells; similar labelling was also observed in light-adapted chicken retinae. The pattern of labelling in the fish and chicken retinae was modified by dark adaptation, when labelling was greatly reduced in the horizontal cells, indicating the activity dependence of GABA (analogue) transport. Intraperitoneal injection of gamma-vinyl GABA into rats resulted in its transport across the blood-brain barrier and subsequent uptake into populations of GABAergic neurons. The other analogues investigated in this study exhibited different patterns of transport; gabaculine was taken up into glial cells, whilst diaminobutyric acid was taken up into neurons, glial cells and retinal pigment epithelia. Thus, these analogues are probably substrates for different GABA transporters. We conclude that immunocytochemical detection of the high-affinity uptake of gamma-vinyl GABA permits the identification of GABAergic neurons which are actively transporting GABA, and suggest that this novel methodology will be a useful tool in rapidly assessing the recent activity of GABAergic neurons at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809830     DOI: 10.1016/0306-4522(96)00097-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers.

Authors:  I Nousiainen; R Kälviäinen; M Mäntyjärvi
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  The effect of GABA and the GABA-uptake-blocker NO-711 on the b-wave of the ERG and the responses of horizontal cells to light.

Authors:  Renate Hanitzsch; Lea Küppers; Andreas Flade
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

Review 3.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Expression of the gamma-aminobutyric acid (GABA) plasma membrane transporter-1 in monkey and human retina.

Authors:  Giovanni Casini; Dennis W Rickman; Nicholas C Brecha
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

5.  The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin.

Authors:  Carol A Westall; William J Logan; Kim Smith; J Raymond Buncic; Carole M Panton; Mohamed Abdolell
Journal:  Doc Ophthalmol       Date:  2002-03       Impact factor: 2.379

6.  Nitric oxide stimulates gamma-aminobutyric acid release and inhibits glycine release in retina.

Authors:  Dou Yu; William D Eldred
Journal:  J Comp Neurol       Date:  2005-03-14       Impact factor: 3.215

7.  The effects of GABA and vigabatrin on horizontal cell responses to light and the effect of vigabatrin on the electroretinogram.

Authors:  R Hanitzsch; L Küppers
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

8.  Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.

Authors:  Sivan Durbin; Giuseppe Mirabella; J Raymond Buncic; Carol A Westall
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-11       Impact factor: 4.799

9.  Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children.

Authors:  J Raymond Buncic; Carol A Westall; Carole M Panton; J Robert Munn; Leslie D MacKeen; William J Logan
Journal:  Ophthalmology       Date:  2004-10       Impact factor: 12.079

10.  GABA and Glutamate Uptake and Metabolism in Retinal Glial (Müller) Cells.

Authors:  Andreas Bringmann; Antje Grosche; Thomas Pannicke; Andreas Reichenbach
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.